Health Catalyst, Inc.
HCAT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.14 | 0.24 | 0.20 | -1.12 |
| FCF Yield | -0.43% | -9.07% | -9.23% | -2.21% |
| EV / EBITDA | -54.27 | -9.74 | -8.48 | -18.62 |
| Quality | ||||
| ROIC | -9.13% | -20.66% | -20.07% | -18.43% |
| Gross Margin | 45.92% | 31.29% | 48.21% | 48.60% |
| Cash Conversion Ratio | -0.21 | 0.28 | 0.26 | 0.15 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.54% | 6.95% | 13.52% | 16.01% |
| Free Cash Flow Growth | 96.12% | 10.05% | -26.67% | -13.59% |
| Safety | ||||
| Net Debt / EBITDA | -14.33 | -2.09 | -1.59 | -0.11 |
| Interest Coverage | -4.09 | -17.41 | -19.34 | -8.30 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 42.91 | 62.44 | 52.10 | 59.85 |